Kianmanesh Reza, Regimbeau Jean Marc, Belghiti Jacques
Department of Surgery, Beaujon Hospital, 100 Boulevard du Gal Leclerc, F-92110 Clichy, France.
Surg Oncol Clin N Am. 2003 Jan;12(1):51-63. doi: 10.1016/s1055-3207(02)00090-x.
For large HCCs, partial liver resection remains the best therapeutic option for cure because neither liver transplantation nor percutaneous treatments are indicated. In specialized centers, a better selection of at-risk patients and technical procedures, including the use of intermittent inflow occlusion and the anterior approach, have contributed to improve dramatically the outcome of major liver resection for HCC in CLD. In addition, portal vein embolization has become an important tool to hypertrophy the future liver remnant before major liver resection in cirrhotic patients with apparently normal liver function.
对于大型肝细胞癌(HCC),部分肝切除仍然是实现治愈的最佳治疗选择,因为肝移植和经皮治疗均不适用。在专业中心,对高危患者和技术操作进行更优选择,包括采用间歇性入肝血流阻断和前入路,已显著改善了肝硬化(CLD)患者行HCC大肝切除的预后。此外,门静脉栓塞已成为在肝功能明显正常的肝硬化患者进行大肝切除前使未来肝残余体积增大的重要手段。